These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2895004)

  • 1. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.
    Battaglia G; Norman AB; Creese I
    Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
    Norman AB; Battaglia G; Creese I
    J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
    Battaglia G; Norman AB; Creese I
    J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
    Henry JM; Roth GS
    Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor turnover rates in rat striatum are age-dependent.
    Leff SE; Gariano R; Creese I
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3910-4. PubMed ID: 6587399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours.
    Farabegoli C; Merlo Pich E; Cimino M; Agnati LF; Fuxe K
    Acta Physiol Scand; 1988 Feb; 132(2):209-16. PubMed ID: 2906500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM; Joseph JA; Kochman K; Roth GS
    Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS; George T; Baldessarini RJ
    Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in the turnover rates of D1-dopamine receptors in the retina and in distinct areas of the rat brain.
    Giorgi O; Pibiri MG; Dal Toso R; Ragatzu G
    Brain Res; 1992 Jan; 569(2):323-9. PubMed ID: 1347246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with SCH 23390 increases the production rate of dopamine D1 receptors in the nigro-striatal system of the rat.
    Giorgi O; Pibiri MG; Loi R; Corda MG
    Eur J Pharmacol; 1993 Apr; 245(2):139-45. PubMed ID: 8098282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.